ebrotidine has been researched along with tyrosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Czajkowski, A; Piotrowski, J; Slomiany, A; Slomiany, BL; Yotsumoto, F | 1 |
2 other study(ies) available for ebrotidine and tyrosine
| Article | Year |
|---|---|
Inhibition of EGF-induced gastric mucosal calcium channel phosphorylation by ebrotidine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Ulcer Agents; Benzenesulfonates; Calcium Channels; Calcium Radioisotopes; Epidermal Growth Factor; Gastric Mucosa; Isradipine; Phosphorylation; Phosphotyrosine; Rats; Thiazoles; Tyrosine | 1992 |
Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
Topics: Animals; Benzenesulfonates; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Gastric Mucosa; Histamine H2 Antagonists; Phosphorylation; Platelet-Derived Growth Factor; Ranitidine; Rats; Receptors, Platelet-Derived Growth Factor; Thiazoles; Tyrosine | 1993 |